Nostos Genomics is dedicated to improving the diagnosis of rare genetic diseases through its AI-driven variant interpretation platform, AION. The company addresses the bottleneck in genomics not in sequencing DNA but in interpreting genetic variants to identify disease-causing mutations accurately and swiftly.

The vision of Nostos Genomics is to help people with genetic diseases start a new journey by improving the accuracy, speed, and accessibility of genetic testing, empowering patients with timely and reliable information for informed health decisions.

Our platform automates and accelerates genetic testing labs' ability to diagnose genetic diseases, enabling more people to receive clear and fast diagnoses. AION can identify likely pathogenic variants in less than 2 minutes, providing comprehensive reports and result exports.

Supported by a multidisciplinary team with expertise spanning software, data science, genetics, and healthcare, Nostos Genomics collaborates with leading global genomics institutions and is guided by prominent scientific advisors to overcome the challenges in genetic variant interpretation.